US Patent No 6630507

I am borrowing this picture above that was posted on the internet.  I've noticed that the US Patent # posted on the picture is not the same Patent # I am sharing with you here.  I have not yet researched for the Patent # mentioned in the picture but I do have information below on Patent # 6630507

US Patent 6630507 -

Cannabinoids as antioxidants and neuroprotectants

The US government holds a patent on medical hemp unlike many of us were led to believe.  Many of us were under the impression that it was a major drug company which held the patent.

We confirmed it at the patent office, that the United States Government, who has imprisoned and caused the untimely deaths of many over the issue of marijuana/hemp, holds a patent on medical hemp. They made it illegal for us to study and use one of the most effective medicines on the planet while they took their time getting a patent on it.

The Department of Health and Human Services hold the patent 6630507, Cannabinoids as antioxidants and neuroprotectants, a medical hemp patent.

Below is the text of the patent, US Patent No 6630507,

US Patent Issued on October 7, 2003

Abstract

Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases.

The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in theatreatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, HIV  and dementia. 

Nonpsychoactive cannabinoids, such as cannabid oil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.

A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula(I) where in the R group is independently selected from the group consisting of H, CH3, and COCH3. ##STR1##

Inventor(s) Hampson, Aidan J.
Axelrod, Julius
Grimaldi, Maurizio

Assignee The United States of America as represented by the Department of Health and Human Services


ApplicationNo. 09/674028 filed on 02/02/2001

Current US Class 514/454 Tricyclo ring system having the hetero ring as one of the cyclos

Field of Search 514/454 Tricyclo ring system having the hetero ring as one of the cyclos

ExaminersPrimary: Weddington, Kevin E.

Attorney, Agent or Firm Klarquist Sparkman, LLP

US Patent References 2304669, 4876276, (3S-4S)-7-hydroxy-Ɗ6 -tetrahydrocannabinols Issued on: 10/24/1989 Inventor: Mechoulam, et al.5227537,   Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof for the production of trans-delta-9-tetrahydrocannabinol Issued on: 07/13/1993 Inventor: Stoss, et al.5284867, NMDA-blocking pharmaceutical compositions Issued on: 02/08/1994 Inventor: Kloog, et al.5434295, Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds Issued on: 07/18/1995 Inventor: Mechoulam, et al.5462946, Nitroxides as protectors against oxidative stress Issued on: 10/31/1995 Inventor: Mitchell, et al.5512270, Method of inhibiting oxidants using alkylaryl polyether alcohol polymers Issued on: 04/30/1996 Inventor: Ghio, et al.5521215, NMDA-blocking pharmaceuticals Issued on: 05/28/1996 Inventor: Mechoulam, et al.5538993, Certain tetrahydrocannabinol-7-oic acid derivatives Issued on: 07/23/1996 Inventor: Mechoulam, et al.5635530, (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them Issued on: 06/03/1997 Inventor: Mechoulam, et al.5696109, Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease Issued on: 12/09/1997 Inventor: Malfroy-Camine, et al.6410588 Use of cannabinoids as anti-inflammatory agents Issued on: 06/25/2002 Inventor: Feldmann, et al.International classA61K 31/35 (20060101)

Other References

Windholz et al., The Merck Index, Tenth Edition (1983) p. 241, abstract No. 1723.
Mechoulam et al., "A Total Synthesis of d1-Ɗ1 -Tetrahydrocannabinol, the Active Constituent of Hashish1," Journal of the American Chemical Society, 87:14:3273-3275 (1965)
Mechoulam et al., "Chemical Basis of Hashish Activity," Science, 18:611-612 (1970)
Ottersen et al., "The Crystal and Molecular Structure of Cannabidiol," Acta Chem. Scand. B 31, 9:807-812 (1977)
Cunha et al., "Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients1," Pharmacology, 21:175-185 (1980)
Consroe et al., "Acute and Chronic Antiepileptic Drug Effects in Audiogenic Seizure-Susceptible Rats," Experimental Neurology, Academic Press Inc., 70:626-637 (1980)
Turkanis et al., "Electrophysiologic Properties of the Cannabinoids," J. Clin. Pharmacol., 21:449S-463S (1981)
Carlini et al., "Hypnotic and Antielpileptic Effects of Cannabidiol," J. Clin. Pharmacol., 21:417S-427S (1981)
Karler et al., "The Cannabinoids as Potential Antiepileptics," J. Clin. Pharmacol., 21:437S-448S (1981)
Consroe et al., "Antiepileptic Potential of Cannabidiol Analgos," J. Clin. Pharmacol., 21:428S-436S (1981)
Colasanti et al., "Ocular Hypotension, Ocular Toxicity,a nd Neurotoxicity in Response to Marihuana Extract and Cannabidiol," Gen Pharm., Pergamon Press Ltd., 15(6):479-484 (1984)
Colasanti et al., "Intraocular Pressure, Ocular Toxicity and Neurotoxicity after Administration of Cannabinol or Cannabigerol," Exp. Eye Res., Academic Press Inc., 39:251-259 (1984)
Volfe et al., "Cannabinoids Block Release of Serotonin from Platelets Induced by Plasma frm Migraine Patients," Int. J. Clin. Pharm. Res., Bioscience Ediprint Inc., 4:243-246 (1985)
Agurell et al., "Pharmacokinetics and Metabolism of Ɗ1 -Tetrahydrocannabinol and Other Cannabinoids with Emphasis on Man*," Pharmacological Reviews, 38(1):21-43 (1986)
Karler et al., "Different Cannabinoids Exhibit Different Pharmacological and Toxicological Properties,"NIDA Res. Monogr., 79:96-107 (1987)
Samara et al., "Pharmacokinetics of Cannabidiol in Dogs," Drug Metabolism and Disposition, 16(3):469-472 (1988)
Choi, "Glutamate Neurotoxicity and Diseases of the Nervous System," Neuron, Cell Press, 1:623-634 (1988)
Eshhar et al., "Neuroprotective and Antioxidant Activities of HU-211, A Novel NMDA Receptor Antagonist," European Journal of Pharmacology, 283:19-29 (1995)
Skaper et al., "The ALIAmide Palmitoylethanolamide and Cannabinoids, but not Anandamide, are Protective in a Delayed Postglutamate Paradigm of Excitotoxic Death in Cerebellar Granule Neurons," Neurobiology, Proc. Natl. Acad. Sci. USA, 93:3984-3989 (1996)
Alonso et al., "Simple Synthesis of 5-Substituted Resorcinols: A Revisited Family of Interesting Bioactive Molecules," J. Org. Chem., American Chemical Society, 62(2):417-421 (1997)
Combes et al. "A Simple Synthesis of the Natural 2,5-Dialkylresorcinol Free Radical Scavenger Antioxidant: Resorstation," Synthetic Communications, Marcel Dekker, Inc., 27(21):3769-3778 (1997)
Shohami et al., "Oxidative Stress in Closed-Head Injury: Brain Antioxidant Capacity as an Indicator of Functional Outcome," Journal of Cerebral Blood Flow and Metabolism, Lippincott-Raven Publishers, 17(10):1007-1019 (1997)
Zurier et al., "Dimethylheptyl-THC-11 OIC Acid," Arthritis & Rheumatism, 41(1):163-170 (1998)
Hampson et al., "Dual Effects of Anandamide on NMDA Receptor-Mediated Responses and Neurotransmission," Journal of Neurochemistry, Lippincott-Raven Publishers, 70(2):671-676 (1998)
Hampson et al., "Cannabidiol and (-)Ɗ9 -tetrahydrocannabiono are Neuroprotective Antioxidants," Medical Sciences, Proc. Natl. Acad. Sci. USA, 8268-8273 (1998)

Posted by J. Nayer Hardin at 6:11 PM

CANNABIS EXTRACT

Merits of Cannabis Extract

Last semester, I ran an event through Students for Sensible Drug Policy about cannabis extract medicine. During the presentation, my friend Corrie Yelland discussed how she cured her anal canal cancer with only cannabis oil — no traditional treatments. Two years ago, I held a similar presentation with Dennis Hill, another friend with aggressive prostate cancer who went into remission using only cannabis oil.   

These successes were achieved without chemotherapy, radiation or surgery. Furthermore, these two individuals were confident in this course of treatment because of the hundreds of other people who have eliminated cancer and other serious diseases with cannabis extracts, in the form of oil.

It is important to point out that cannabis oil treatments consist of ingesting massive quantities of the extract over time — at least 60 grams in 3 months — and do not involve smoking, which is the most familiar form of medicinal cannabis use, but is also by far the least effective. Medicine is meant to be ingested, not smoked. Yet millions of people have found that just smoking cannabis is more effective than many vigorously researched pharmaceuticals for pain reduction.

If such patients began to ingest cannabis oil instead of smoking, many would cure their ailments instead of simply managing them.

I would like to address the No. 1 concern people have with this seemingly outrageous claim: If cannabis oil really cures cancer, why isn’t it being used on a widespread basis, or at least being discussed further?

First of all, oil is used on a relatively significant scale — I can provide more than 120 testimonials to anyone who wants them. But compared to those who smoke cannabis or people who don’t use cannabis at all, those rates are extremely low.

Second, many people who use this treatment don’t come forward because they fear social stigmas, law enforcement or simply don’t want to talk about such a personal issue. Those who do come forward to their doctors or the media are usually dismissed. Doctors attribute cannabis-related cures to spontaneous remission or faulty diagnoses, and the media rarely wants to damage its credibility by having a story about cannabis curing cancer, which initially sounds insane.

It takes a lot of research and conversations with patients to truly understand this issue, and most people in power aren’t willing to take the time to do that.

Nonetheless, the cannabis extract movement is growing, and the media is slowly beginning to pay attention. Dr. William Courtney appeared in a video on The Huffington Post on Dec. 1, discussing how he cured an 8-month-old of brain cancer with just oil (once again, no chemotherapy, radiation or surgery), as well as his cure of a different terminal cancer patient by juicing cannabis.

Dr. Robert Melamede has made news with his publicly traded corporation Cannabis Science’s cures of skin cancer. Today, a group of oil producers and patients in Michigan are holding a “Cannabis Cures Cancer” concert — their second concert of this type — to spread the message.

Furthermore, there have been five documentaries made about cannabis oil curing cancer, and several local news affiliates in Canada and the U.S. have actually run stories about individual patients. Over the past five years, I’ve seen this movement grow from being concentrated mainly in Canada to exploding in Colorado, Washington and Oregon (though surprisingly not too much in California).

This phenomenal growth has only one root — the evidence that cannabis oil works, and that, in my experience, it works better than any other medicine humans currently have access to.

I am happy to share any information I have with anyone who wants it, and connect you with real patients who have been cured of cancer with cannabis oil. I guarantee no matter how skeptical you are, if you look into this matter deeply, you will see how profoundly true and important this really is.

Source: DiamondBackOnline
Justin Kander is a senior marketing major. He can be reached at jkander@umd.edu.